Argonaut Manufacturing Services Inc.

We will be at TIDES 2025 in San Diego and look forward to connecting with you to discuss your aseptic fill finish needs for vials, syringes, and cartridges. Whether you’re ready to move forward with a specific project or are exploring your outsourcing options, our team is here to support you.   Meet us at booth 104 or reach out to Scott Goldstein, Sylvia Hinds or Raj Puri  today to schedule a meeting and learn more about how we can collaborate.   At Argonaut, we guide you through every step of the process—from tech transfer to final release—ensuring a smooth transition and successful campaigns from clinical to commercial manufacturing.   Why choose Argonaut?  - Expertise in vials, syringes, and cartridges  - Advanced capacity: 500–12,600 units per hour  - ISO 5/Grade A isolators for safety and quality  - Near-zero API loss for high-value products  - Responsive and flexible - Comprehensive services: formulation, sterilization, cGMP storage, and logistics    Our aseptic fill finish capabilities support a wide range of products:  - Biologics, including mAbs, proteins, plasmids, and enzymes  - Small molecules, peptides, and oligos such as mRNA and siRNA  - Vaccines, adjuvants, and diluents    Let’s explore how our expanding capabilities can align with your manufacturing needs. We look forward to seeing you at #TIDES2025. #AsepticFillFinish #CDMO

Register now for Outsourced Pharma capacity update session on April 25. Gain expert insights from Scott Goldstein about precision filling with minimal line losses, maintaining high product quality and process efficiency in aseptic fill finish. Use this link to sign up: https://lnkd.in/gdFxhtaP

Learn about the fundamental parameters of quality control that improves the consistency and output of a diagnostic device incorporating lyophilization. Applying Quality by Design (QbD) ensures consistency by defining and controlling critical parameters throughout the manufacturing process. A deep understanding of the process allows teams to quickly trace the root cause of failures and protect product quality.   For diagnostics that rely on lyophilized components, strong process control isn't just important - it's essential. https://lnkd.in/gSi3hMgD

It is a privilege to highlight the outstanding contributions of Richard J. Hargis, Sr. Director of Drug Product Manufacturing. His work sets a high standard for us all. In Richard's words: “Our work directly impacts patient outcomes, even though we don’t always see the end results. One of the most rewarding parts of my role is working on ‘N of One’ projects. These are unique manufacturing runs designed for individual patients with ultra-rare diseases. Knowing that our efforts directly affect someone's health gives our work an incredible sense of purpose.” Learn more about Richard and the difference he is making at Argonaut by clicking the link below: https://lnkd.in/deM_eKbf

Sign up now and get expert advice from Scott Goldstein about precision filling with minimal line losses, maintaining high product quality and process efficiency in aseptic fill finish.

We are at PDA Week 2025 and look forward to connecting with you to discuss your aseptic fill finish needs for vials, syringes, and cartridges. Whether you’re ready to move forward with a specific project or are exploring your outsourcing options, our team is here to support you. Meet us at booth 608 or reach out to Scott Goldstein, Sylvia Hinds, Eugene Chow or Raj Puri today to schedule a meeting and learn more about how we can collaborate. At Argonaut, we guide you through every step of the process—from tech transfer to final release—ensuring a smooth transition and successful campaigns from clinical to commercial manufacturing. Why choose Argonaut?  - Expertise in vials, syringes, and cartridges  - Advanced capacity: 500–12,600 units per hour  - ISO 5/Grade A isolators for safety and quality  - Near-zero API loss for high-value products  - Responsive and flexible - Comprehensive services: formulation, sterilization, cGMP storage, and logistics Our aseptic fill finish capabilities support a wide range of products:  - Biologics, including mAbs, proteins, plasmids, and enzymes  - Small molecules, peptides, and oligos such as mRNA and siRNA  - Vaccines, adjuvants, and diluents Let’s explore how our expanding capabilities can align with your manufacturing needs. We look forward to seeing you at #PDAweek 2025. #AsepticFillFinish #CDMO

4 tips on choosing the right CMO for your biopharmaceutical. If your current CMO isn’t meeting your expectations, it may be time to transition to a partner who can better support your manufacturing goals. Choosing the right CMO for biopharma growth means securing real-time quality oversight, structured program management, streamlined testing workflows, scalable infrastructure, and strategic collaboration with third-party partners to ensure timely, accurate, and compliant drug production. Read the post in this link to learn what to look for in a CMO: https://lnkd.in/dZQJR2pi

We’re #hiring a new Director / Sr. Director, Business Development & Strategic Partnerships, Drug Product in Boston, Massachusetts. Apply today or share this post with your network.

We’ll be at PDA Week 2025 next week and look forward to connecting with you to discuss your aseptic fill finish needs for vials, syringes, and cartridges. Whether you’re ready to move forward with a specific project or are exploring your outsourcing options, our team is here to support you. Meet us at booth 608 or reach out to Scott Goldstein, Sylvia Hinds, or Raj Puri today to schedule a meeting and learn more about how we can collaborate. At Argonaut, we guide you through every step of the process—from tech transfer to final release—ensuring a smooth transition and successful campaigns from clinical to commercial manufacturing. Why choose Argonaut?  - Expertise in vials, syringes, and cartridges  - Advanced capacity: 500–12,600 units per hour  - ISO 5/Grade A isolators for safety and quality  - Near-zero API loss for high-value products  - Responsive and flexible - Comprehensive services: formulation, sterilization, cGMP storage, and logistics Our aseptic fill finish capabilities support a wide range of products:  - Biologics, including mAbs, proteins, plasmids, and enzymes  - Small molecules, peptides, and oligos such as mRNA and siRNA  - Vaccines, adjuvants, and diluents Let’s explore how our expanding capabilities can align with your manufacturing needs. We look forward to seeing you at #PDAweek 2025. #AsepticFillFinish #CDMO

Get high-quality reagents and kits from Argonaut Manufacturing Services—your trusted FDA-registered and inspected partner in life sciences and IVD manufacturing. With over 4.2 million kits produced since 2016, our 100K sq. ft. state-of-the-art facilities ensure reliable, consistent solutions from development to global distribution. Argonaut Manufacturing Services - Reagents Made Right®.